State Of Wyoming Repare Therapeutics Inc. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$9.32 - $15.06 $51,045 - $82,483	5,477 New	5,477 $53,000
Q2 2022 Aug 15, 2022	SELL	$8.45 - $14.84 $9,117 - $16,012	-1,079 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$11.38 - $21.88 $5,200 - $9,999	457 Added 73.47%	1,079 $15,000
Q4 2021 Feb 11, 2022	BUY	$19.66 - $28.11 $2,162 - $3,092	110 Added 21.48%	622 $13,000
Q3 2021 Feb 11, 2022	SELL	$25.71 - $35.24 $7,815 - $10,712	-304 Reduced 37.25%	512 $13,000
Q2 2021 Feb 11, 2022	BUY	$30.1 - $34.85 $14,899 - $17,250	495 Added 154.21%	816 $25,000
Q1 2021 Feb 08, 2022	BUY	$25.89 - $44.46 $8,310 - $14,271	321 New	321 $10,000

35.4M

51K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $51.2M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.